reply to post by DigitalSea
In Australia, they have government health care, so you do not get expensive medicine because the gov is about saving money, not the lives of
everybody, and yes, they are the defacto 'death panel'. The government is worst than any insurance company.
In the USA, I get whatever I drug or treatment I need since I PAY FOR IT. Only thing that is not covered is experimental drugs but if I choose the
experimental medicine, they will pay for the doctor's portion of oversight and admin.
On Drugstore.com, price is much lower, one injection vial per week is about $525
1 vial $575.99 - save 5% ($32.04)
3 vials $1,625.88 - save 11% ($198.20)
6 vials $3,210.02 - save 12% ($438.13)
Here is another article on this new drug:
The high cost discussed is the market price,
June 29 (Bloomberg) -- Eli Lilly & Co.’s tumor-fighter Erbitux doesn’t prolong lung cancer patients’ lives enough to justify its $80,000 cost,
U.S. scientists said in commentary published today.
Erbitux added to other cancer drugs extends survival about 1.2 months more than chemotherapy alone, making the price too high for a “marginal
benefit,” commentary in the Journal of the National Cancer Institute said. Erbitux, which Lilly markets with Bristol-Myers Squibb Co., generated
$1.3 billion last year as treatment approved for other malignancies.
The high price of some of the newest cancer medicines are coming under scrutiny as part of an effort by lawmakers and health officials to rein in
overall medical costs. President Barack Obama has set aside $1.1 billion in the U.S. economic stimulus bill to study the comparative effectiveness of
treatments for cancer and other diseases.
“We must avoid the temptation to tell a patient that a new drug is available if there is little evidence that it will work better than established
drugs that could be offered at a miniscule fraction of the cost,” wrote the commentators, Tito Fojo with the National Cancer Institute and Christine
Grady at the National Institutes of Health.
Lilly, of Indianapolis, and marketing partner Bristol- Myers, of New York, withdrew an application to extend the Erbitux’s use to lung tumors in
February after the Food and Drug Administration questioned differences in American and European versions of the treatment.
$10,000 a Month
The authors projected that Erbitux costs $80,000 based on a typical course of treatment for lung tumors, 18 weeks. If all 550,000 U.S. patients who
die of cancer each year took 12 months of Erbitux, the total cost would be $440 billion, 100 times the annual budget of the National Cancer Institute,
the authors said.